What test should be ordered for proof of MMR (Measles, Mumps, and Rubella) vaccination?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What to Order for MMR Titer Proof of Vaccination

Order serologic testing for IgG antibodies to measles, mumps, and rubella using any standard, licensed enzyme immunoassay (EIA). 1, 2, 3

Specific Test to Order

  • Request: "MMR IgG antibody panel" or individual IgG antibodies for measles, mumps, and rubella 1, 2, 3
  • Any antibody level above the standard positive cutoff value of a licensed assay is considered acceptable evidence of immunity 2, 3
  • The demonstration of IgG antibody by any commonly used serologic assay is acceptable evidence of immunity according to the CDC 2, 3

What Constitutes Laboratory Evidence of Immunity

For Measles:

  • Positive measles IgG antibody detected by any standard serologic test 3
  • Any level above the positive cutoff is considered evidence of immunity 3

For Mumps:

  • Demonstration of mumps IgG antibody by any commonly used serologic assay 2
  • Any antibody level above the standard positive cutoff value indicates immunity 2
  • Immunity is suggested by the presence of antimumps IgG-class antibodies 2

For Rubella:

  • Laboratory evidence of immunity is defined as positive rubella IgG 1
  • Any standard serologic test showing positive IgG is acceptable 1

Critical Caveats

Equivocal Results:

  • Persons with "equivocal" serologic test results should be considered susceptible to measles unless they have other evidence of immunity (such as documented vaccination or birth before 1957) 3
  • For healthcare personnel with documented MMR vaccination who test negative or equivocal, documented age-appropriate vaccination supersedes the serologic results—they should still be considered immune 1

When NOT to Order Titers:

  • Do not order titers for persons with documented age-appropriate vaccination unless the medical facility considers it cost-effective 1
  • Prevaccination antibody screening before MMR vaccination is not necessary for healthcare personnel without adequate presumptive evidence of immunity 1
  • During outbreaks, serologic screening before vaccination is not recommended because rapid vaccination is necessary 1

Alternative Evidence of Immunity (Non-Laboratory)

If documentation exists, laboratory testing may not be necessary 1:

For Measles:

  • Written documentation of 2 doses of live measles or MMR vaccine administered at least 28 days apart 1
  • Birth before 1957 (with caveats for healthcare workers) 1, 3

For Mumps:

  • Written documentation of 2 doses of live mumps or MMR vaccine administered at least 28 days apart 1
  • Birth before 1957 1

For Rubella:

  • Written documentation of 1 dose of live rubella or MMR vaccine 1
  • Birth before 1957 (except women of childbearing potential) 1

Important Testing Considerations

  • IgM testing is NOT appropriate for determining immunity status—IgM is only used for diagnosing acute infection 3
  • Enzyme immunoassays (EIAs) are the most commonly used commercial assays, having replaced older hemagglutination inhibition tests 2
  • Commercially available antibody assays do not measure functional (neutralizing) antibodies and were designed to measure naturally acquired antibodies rather than vaccine-induced antibodies 4
  • There is no reliable serologic correlate of protection for mumps specifically 4

Special Populations

Healthcare Workers:

  • All healthcare personnel should have presumptive evidence of immunity documented and readily available 1
  • Approximately 4-10% of healthcare personnel lack measles IgG antibodies, even among those born before 1957 3
  • For healthcare workers with documented vaccination who test negative/equivocal, do not give additional doses based on serology alone—consider them immune 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Mumps Immunity Interpretation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Laboratory Evidence of Measles Immunity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Titerphilia - The Irresistible Urge to Measure Postimmunization Antibody Values.

The Pediatric infectious disease journal, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.